Elevance Health, Inc. (ELV)
NYSE · Healthcare · Healthcare Plans
$394.51+2.09%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $85.6B
- P/E (trailing)
- 17.5
- Forward P/E
- 13.4
- Dividend yield
- 1.7%
- 52-week range
- $274.84 – $436.24
- 52-week change
- +10.43%
- EPS (trailing)
- $22.59
- Analyst rating
- 1.8 Buy
- Next earnings
- Oct 21, 2026
Fiscal year to Dec 2025
- Revenue
- $199B (+12.50%)
- Net income
- $5.7B
- Operating margin
- 3.6%
- Diluted EPS
- $25.21
- Free cash flow
- $3.2B
From the company’s annual report on SEC EDGAR.
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers.
Headquarters: Indianapolis, United States · 96,129 employees · elevancehealth.com